Table 2.
Number of cases (No.) and 5-year Relative Survival (RS%) with 95% CI for epithelial H and N cancers in Europe (RARECAREnet) and years of diagnosis 2000 to 2007.
| H and N cancers | Age group | ||||||
|---|---|---|---|---|---|---|---|
| 25 to 64 | 65+ | ||||||
| No. | 5-year RS (95% CI) | CS(%) | No. | 5-year RS (95% CI) | CS(%) | 5-year survival progress* | |
| Epithelial tumors of the nasal cavity and sinuses | 3,055 | 53 (51-55) | 67 | 3,777 | 42 (40-45) | 61 | +5% |
| Epithelial tumors of the nasopharynx | 4,791 | 55 (53-56) | 67 | 2,157 | 31 (29-34) | 51 | +2% |
| Epithelial tumors of major salivary glands | 6,703 | 70 (69-71) | 80 | 7,625 | 50 (49-52) | 67 | +2% |
| Salivary gland-type tumors of the head and neck | 3,574 | 71 (70-73) | 80 | 2,992 | 60 (58-63) | 73 | +2% |
| Squamous cell carcinoma of the hypopharynx | 13,136 | 27 (26-27) | 42 | 6,739 | 22 (21-24) | 39 | +4% |
| Squamous cell carcinoma of the larynx | 38,749 | 62 (61-62) | 72 | 33,155 | 59 (58-60) | 71 | 0% |
| Epithelial tumors of the oropharynx | 35,409 | 44 (43-44) | 59 | 15,411 | 34 (33-35) | 54 | +7% |
| Squamous cell carcinoma of the oral cavity | 31,440 | 50 (49-50) | 64 | 22,688 | 46 (45-47) | 65 | +4% |
CS= is the conditional 5-year survival, the probability of surviving an additional 4 years on the condition that the patient has survived 1 year.
*=from 1999 to 2002 and 2005 to 2007, all ages.